Evidence Synthesis
Bafna Pharmaceuticals (BAFNAPH) experienced a standard shift in the Indian equity market on 2026-09-05.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 02:57
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Bafna Pharmaceuticals (BAFNAPH) experienced a standard shift in the Indian equity market on 2026-09-05.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 31.57 % | -3.38 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -3.38 % | 5.46 | ▼ |
| REVENUE_GROWTH_YOY | -23.2 % | -97.9 | ▲ |
| PRICE_CHANGE_PERCENT | -1.988 % | — | - |
| DAILY_VOLUME | 4,794 shares | 28,946 | ▼ |
| CLOSE_PRICE | 295.85 INR | 301.85 | ▼ |